MCID: HYP087
MIFTS: 40

Hypotrichosis

Categories: Eye diseases, Genetic diseases, Oral diseases, Rare diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Hypotrichosis

MalaCards integrated aliases for Hypotrichosis:

Name: Hypotrichosis 11 75 28 43 14 38 75

Classifications:



External Ids:

Disease Ontology 11 DOID:4535
MeSH 43 D007039
SNOMED-CT 68 53602002
UMLS 71 C0020678

Summaries for Hypotrichosis

Disease Ontology: 11 A hair disease that is characterized by sparse hair on the scalp resulting from abnormal hair follicle development and has material basis in mutations in proteins involved in hair growth, division or proliferation of cells within hair follicles.

MalaCards based summary: Hypotrichosis is related to hypotrichosis 7 and hypotrichosis, congenital, with juvenile macular dystrophy. An important gene associated with Hypotrichosis is HYPT9 (Hypotrichosis 9), and among its related pathways/superpathways is Keratinization. The drugs Bimatoprost and Minoxidil have been mentioned in the context of this disorder. Affiliated tissues include skin, bone and bone marrow, and related phenotypes are endocrine/exocrine gland and integument

Wikipedia: 75 Hair loss, also known as alopecia or baldness, refers to a loss of hair from part of the head or body.... more...

Related Diseases for Hypotrichosis

Diseases in the Hypotrichosis family:

Hypotrichosis 2 Hypotrichosis 4
Hypotrichosis 8 Hypotrichosis 7
Hypotrichosis 1 Hypotrichosis 6
Hypotrichosis 5 Hypotrichosis 3
Hypotrichosis 9 Hypotrichosis 10
Hypotrichosis 11 Hypotrichosis 12
Hypotrichosis 13 Hypotrichosis 14

Diseases related to Hypotrichosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 293)
# Related Disease Score Top Affiliating Genes
1 hypotrichosis 7 33.1 SNRPE LPAR6 LIPH KRT74 KRT25 DSG4
2 hypotrichosis, congenital, with juvenile macular dystrophy 33.0 LPAR6 LIPH DSG4 CDSN CDH3
3 hypotrichosis 1 33.0 LIPH KRT74 APCDD1
4 hypotrichosis 3 32.9 LPAR6 LIPH KRT74 KRT71
5 hypotrichosis 6 32.9 SNRPE LPAR6 LIPH KRT74 KRT71 DSG4
6 hypotrichosis 2 32.8 LSS LPAR6 LIPH KRT74 DSG4 CDSN
7 hypotrichosis 4 32.8 SNRPE LPAR6 LIPH KRT74 KRT71 HRURF
8 hypotrichosis 8 32.7 SNRPE LPAR6 LIPH KRT74 KRT71 KRT25
9 hypotrichosis simplex 32.6 SNRPE RPL21 LSS LPAR6 LIPH DSG4
10 hypotrichosis 11 32.6 SNRPE LPAR6 LIPH KRT74 DSG4 CDSN
11 marie unna congenital hypotrichosis 32.6 HR EPS8L3
12 hypotrichosis 13 32.5 SNRPE LPAR6 LIPH KRT74 KRT71 KRT25
13 hypotrichosis simplex of the scalp 32.5 KRT74 CDSN
14 woolly hair, autosomal recessive 3 32.4 LPAR6 LIPH KRT25
15 ectodermal dysplasia, ectrodactyly, and macular dystrophy syndrome 32.2 DSG4 CDSN CDH3
16 ectodermal dysplasia 4, hair/nail type 32.0 LPAR6 LIPH KRT74 KRT71 DSG4
17 monilethrix 31.9 LPAR6 LIPH KRT74 KRT71 KRT25 DSG4
18 ectodermal dysplasia 7, hair/nail type 31.9 KRT74 DSG4
19 ectodermal dysplasia 6, hair/nail type 31.7 KRT74 DSG4
20 ectodermal dysplasia 5, hair/nail type 31.7 KRT74 DSG4
21 familial woolly hair syndrome 31.1 LPAR6 LIPH KRT74 KRT71 KRT25 GJA1
22 skin disease 30.7 GJA1 DSG4 DSC3 CDSN CDH3
23 hair disease 30.6 SOX18 LPAR6 LIPH KRT74 KRT71 DSG4
24 woolly hair, autosomal dominant 30.5 LPAR6 LIPH KRT74 KRT71 KRT25
25 atrichia with papular lesions 30.5 LPAR6 LIPH KRT74 HR DSG4 CDSN
26 darier-white disease 30.4 DSG4 DSC3 CDH3
27 pemphigus 30.1 DSG4 DSC3 CDH3
28 pemphigus vulgaris, familial 30.1 DSG4 DSC3 CDH3
29 hypotrichosis-lymphedema-telangiectasia syndrome 11.7
30 ichthyosis, congenital, autosomal recessive 11 11.6
31 hypotrichosis 5 11.6
32 schopf-schulz-passarge syndrome 11.5
33 hypotrichosis-lymphedema-telangiectasia-renal defect syndrome 11.5
34 hypotrichosis 14 11.5
35 hypotrichosis and recurrent skin vesicles 11.5
36 metaphyseal dysplasia without hypotrichosis 11.5
37 hypotrichosis 12 11.5
38 short stature, onychodysplasia, facial dysmorphism, and hypotrichosis 11.4
39 spondyloepimetaphyseal dysplasia with hypotrichosis 11.4
40 hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome 11.4
41 erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige 11.4
42 hypotrichosis 10 11.3
43 ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis 11.3
44 cartilage-hair hypoplasia 11.3
45 palmoplantar keratoderma and congenital alopecia 1 11.3
46 leukomelanoderma, infantilism, mental retardation, hypodontia, hypotrichosis 11.3
47 hypotrichosis 9 11.3
48 bazex syndrome 11.2
49 hypotrichosis-deafness syndrome 11.2
50 rombo syndrome 11.2

Graphical network of the top 20 diseases related to Hypotrichosis:



Diseases related to Hypotrichosis

Symptoms & Phenotypes for Hypotrichosis

MGI Mouse Phenotypes related to Hypotrichosis:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.61 CDH3 CDSN DSG4 GJA1 HR KRT25
2 integument MP:0010771 9.32 CDH3 CDSN DSC3 DSG4 GJA1 HR

Drugs & Therapeutics for Hypotrichosis

Drugs for Hypotrichosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 31)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bimatoprost Approved, Investigational Phase 4 155206-00-1 5311027
2
Minoxidil Approved, Investigational Phase 4 38304-91-5 4201
3 Antihypertensive Agents Phase 4
4 Pharmaceutical Solutions Phase 4
5 Ophthalmic Solutions Phase 4
6 Vasodilator Agents Phase 4
7 Anti-Bacterial Agents Phase 2
8 Anti-Infective Agents Phase 2
9 Gentamicins Phase 2
10
Glycerin Approved, Investigational 56-81-5 753
11
Zinc cation Approved, Experimental, Investigational 7440-66-6, 23713-49-7 32051
12
Dihydrotachysterol Approved 67-96-9 5311071
13
Capsaicin Approved 404-86-4 1548943
14
Tocopherol Approved, Investigational 1406-66-2
15
Saw palmetto Approved, Experimental, Investigational
16
Curcumin Approved, Investigational 458-37-7, 84765-67-3 969516
17
Ascorbic acid Approved, Nutraceutical 50-81-7 54676860 54670067 5785
18
Biotin Approved, Investigational, Nutraceutical 58-85-5 253 171548
19
DL-alpha-Tocopherol Approved, Experimental, Investigational, Nutraceutical, Vet_approved 59-02-9, 10191-41-0 2116 14985
20
Piperine Investigational 94-62-2 638024
21
Tocotrienol Investigational 6829-55-6 9929901
22 Hormones
23 Maca
24 Vitamin B7
25 Vitamins
26 Ashwagandha
27 Anti-Inflammatory Agents
28 Antioxidants
29 Tocotrienols
30 Tocopherols
31 Saw palmetto extract

Interventional clinical trials:

(show all 30)
# Name Status NCT ID Phase Drugs
1 Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Eyebrow Hypotrichosis: A Phase 4 Investigator Initiated Study Completed NCT01891487 Phase 4 Track A;Track B
2 Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis Completed NCT00958035 Phase 4 bimatoprost ophthalmic 0.03% solution;vehicle sterile solution (placebo)
3 Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children Completed NCT01023841 Phase 4 bimatoprost ophthalmic solution 0.03%;Vehicle Sterile Solution
4 Latisse(Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo Completed NCT01387906 Phase 4 topical bimatoprost
5 Minoxidil 1% for Eyebrow Enhancement: A Randomized , Double-blind , Placebo-controlled , Split-face Comparative Study Completed NCT01924000 Phase 4 Minoxidil lotion 1%;Placebo
6 Efficacy and Tolerability of Minoxidil 2% for Eyebrow Enhancement : A Randomized , Double-blind , Placebo-controlled , Split-face Comparative Study Completed NCT01672307 Phase 4 Minoxidil lotion 2%;Placebo
7 Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects Completed NCT01229423 Phase 4 bimatoprost 0.03%
8 Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence Completed NCT01448525 Phase 4 bimatoprost ophthalmic solution 0.03%;bimatoprost vehicle solution
9 Bimatoprost in the Treatment of Eyelash Hypotrichosis Completed NCT01698554 Phase 3 bimatoprost formulation A solution;bimatoprost solution 0.03 %;vehicle of bimatoprost formulation A solution;vehicle of bimatoprost solution 0.03 %
10 Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin Completed NCT00907426 Phase 3 Bimatoprost 0.03% solution;Vehicle solution
11 Bimatoprost for the Treatment of Eyebrow Hypotrichosis Completed NCT01765764 Phase 3 bimatoprost solution;Vehicle to bimatoprost solution
12 A Multicenter, Double-masked, Randomized, Parallel-group Study Assessing the Safety and Efficacy of Once-daily Application of Bimatoprost Solution 0.03% Compared to Vehicle to Treat Chemotherapy-induced Hypotrichosis of the Eyelashes in Japanese Subjects Completed NCT01391286 Phase 3 bimatoprost solution 0.03%;bimatoprost vehicle solution
13 A Multicenter, Double-masked, Randomized, Parallel-group Study Assessing the Safety and Efficacy of Once-Daily Application of Bimatoprost Solution 0.03% Compared to Vehicle in Increasing Overall Eyelash Prominence in Japanese Subjects With Hypotrichosis of the Eyelashes Completed NCT01391273 Phase 3 bimatoprost solution 0.03%;bimatoprost vehicle solution
14 The Role of Bimatoprost Eyelash Gel in Chemotherapy-induced Madarosis: an Analysis of Efficacy and Safety Completed NCT01200251 Phase 3 Bimatoprost eyelash gel
15 The Efficacy of Topical Gentamycin for the Treatment of Hereditary Hypotrichosis Simplex Caused by Heterozygous Nonsense Mutations in CDSN Encoding Corneodesmosin Unknown status NCT03492866 Phase 2 Gentamicin Sulfate
16 Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence Completed NCT01064882 Phase 2 bimatoprost ophthalmic solution 0.005%;bimatoprost ophthalmic solution 0.015%;bimatoprost ophthalmic solution 0.03%
17 A Pilot Clinical Trial Investigating the Effect of Autologous Platelet-rich Plasma in Subjects With Mild to Moderate Eyebrow Hypotrichosis Recruiting NCT04018859 Phase 2 Saline
18 A Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Ability And Safety Of A Nutraceutical Supplement With Standardized Botanicals To Promote Hair Growth In Perimenopausal, Menopausal And Post-Menopausal Women With Self-Perceived Thinning Hair Unknown status NCT04048031
19 Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan Completed NCT02505776 Bimatoprost cutaneous solution 0.03%
20 An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes Completed NCT01623479 bimatoprost 0.03%
21 A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy of the New Viviscal Professional Strength Oral Supplement in Females With Self-Perceived Thinning Hair Completed NCT02302053
22 A Multi-site, Double-blind, Placebo-controlled Clinical Study to Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair Completed NCT02288858
23 A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Ability Of Viviscal Extra-Strength Formulation To Promote Hair Growth And Decrease Shedding In Women With Self-Perceived Thinning Hair Completed NCT02297360
24 A 6-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability and Safety of a Nutraceutical Supplement With Standardized Botanicals to Promote Hair Growth in Women With Self-Perceived Thinning Hair Completed NCT03206567
25 Hair Regrowth Efficacy of Multi-Molecular Targeting Treatment (ALRV5XR), a Randomized Controlled Clinical Trial in Women With Androgenetic Alopecia, Telogen Effluvium or Self Reported Thinning Hair: THE HAIR REBOOT TRIAL - WOMEN Completed NCT04450602
26 Hair Regrowth Efficacy of Multi-Molecular Targeting Treatment (ALRV5XR), a Randomized Controlled Clinical Trial in Men With Androgenetic Alopecia, Telogen Effluvium or Self Reported Thinning Hair: THE HAIR REBOOT TRIAL - MEN Completed NCT04450589
27 A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of an Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss Active, not recruiting NCT03709563
28 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair Active, not recruiting NCT05339958
29 A Multi-center, Single-arm Prospective Study to Evaluate the Safety and Efficacy of a Nutraceutical Supplement With Vegan Botanicals in Females With Self-Perceived Thinning Hair Active, not recruiting NCT05332743
30 The Effect of an Oral Herbal Combination Formulation on Hair Growth in Women With Self-perceived Hair Loss Withdrawn NCT05019066

Search NIH Clinical Center for Hypotrichosis

Cochrane evidence based reviews: hypotrichosis

Genetic Tests for Hypotrichosis

Genetic tests related to Hypotrichosis:

# Genetic test Affiliating Genes
1 Hypotrichosis 28

Anatomical Context for Hypotrichosis

Organs/tissues related to Hypotrichosis:

MalaCards : Skin, Bone, Bone Marrow, Liver, Eye, Pituitary, Thyroid

Publications for Hypotrichosis

Articles related to Hypotrichosis:

(show top 50) (show all 918)
# Title Authors PMID Year
1
Germline intergenic duplications at Xq26.1 underlie Bazex-Dupré-Christol basal cell carcinoma susceptibility syndrome. 62
35986704 2022
2
Expanding the clinical spectrum of SOX18-related Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome. 62
36096470 2022
3
Loss-of-function mutations in CST6 cause dry skin, desquamation and abnormal keratosis without hypotrichosis. 62
36371786 2022
4
A Case with Hypotrichosis-Lymphedema-Telangiectasia Syndrome with Hair Shaft Fragility. 62
36407647 2022
5
Alopecia and hyperpigmentation in a neonatal patient with lanosterol synthase gene deficiency and Spectrin alpha, non-erythrocytic 1 mutation. 62
35830358 2022
6
Palmoplantar keratoderma: a new phenotype in patients with hypotrichosis resulted from lanosterol synthase gene mutations. 62
35689498 2022
7
Hypotrichosis simplex of the scalp and peeling skin disease, two sides of the same coin. 62
35633076 2022
8
Botanical extracts in combination improve autosomal recessive woolly hair/hypotrichosis caused by LIPH mutations. 62
35238153 2022
9
Different degree of loss-of-function among four missense mutations in the EDAR gene responsible for autosomal recessive hypohidrotic ectodermal dysplasia may be associated with the phenotypic severity. 62
36258277 2022
10
A large deletion encompassing exon 2 of the ectodysplasin A (EDA) gene in a British blue crossbred calf with hypohidrotic ectodermal dysplasia. 62
36068608 2022
11
Extended Overview of Ocular Phenotype with Recent Advances in Hypohidrotic Ectodermal Dysplasia. 62
36138666 2022
12
Cell-trafficking impairment in disease-associated LPA6 missense mutants and a potential pharmacoperone therapy for autosomal recessive woolly hair/hypotrichosis. 62
36173926 2022
13
Hallermann-Streiff syndrome diagnosed in the seventh decade of life. 62
35651595 2022
14
Hallermann Streiff syndrome: Cranio-facial manifestations systematic review and report of two cases. 62
34800747 2022
15
Retinal cadherins and the retinal cadherinopathies: Current concepts and future directions. 62
35066146 2022
16
Uses of eye drops in dermatology, literature review. 62
35652324 2022
17
Treatment of hereditary hypotrichosis simplex of the scalp with oral minoxidil and growth factors. 62
35761391 2022
18
A Novel Pathogenic CDH3 Variant underlying Heredity Hypotrichosis Simplex detected by Whole-Exome Sequencing (WES)-A Case Report. 62
35962736 2022
19
Novel mutations of the ABCA12, KRT1 and ST14 genes in three unrelated newborns showing congenital ichthyosis. 62
35964051 2022
20
Pigmentary retinopathy with perivascular sparing in a SOFT syndrome patient with a novel homozygous splicing variant in POC1A gene. 62
35930384 2022
21
Radiological Findings of Woodhouse-Sakati Syndrome: Cases Reported From Saudi Arabia. 62
36185913 2022
22
The Fate of Epidermal Tight Junctions in the stratum corneum: Their Involvement in the Regulation of Desquamation and Phenotypic Expression of Certain Skin Conditions. 62
35806491 2022
23
Bmal1- and Per2-mediated regulation of the osteogenic differentiation and proliferation of mouse bone marrow mesenchymal stem cells by modulating the Wnt/β-catenin pathway. 62
35386071 2022
24
Novel compound heterozygous cadherin 3 mutations in hypotrichosis and juvenile macular dystrophy. 62
35853629 2022
25
The first reported case of CDH3-related hypotrichosis with juvenile macular dystrophy from Jordan: a case report. 62
35038959 2022
26
Confirmation of a Phenotypic Entity for TSPEAR Variants in Egyptian Ectodermal Dysplasia Patients and Role of Ethnicity. 62
35741818 2022
27
The stem cell quiescence and niche signaling is disturbed in the hair follicle of the hairpoor mouse, an MUHH model mouse. 62
35619120 2022
28
Diffuse congenital hypotrichosis simplex with associated hair shaft fragility. 62
34657286 2022
29
Hypohidrotic ectodermal dysplasia: A case report with review and latest updates. 62
35450227 2022
30
Functional and clinical analysis of five EDA variants associated with ectodermal dysplasia but with a hard-to-predict significance. 62
35923710 2022
31
Three Variants Affecting Exon 1 of Ectodysplasin A Cause X-Linked Hypohidrotic Ectodermal Dysplasia: Clinical and Molecular Characteristics. 62
35873474 2022
32
Hypotrichosis with Juvenile Macular Dystrophy in a Patient with Cadherin 3 (CDH3) Mutation. 62
35996915 2022
33
Update of recent findings in genetic hair disorders. 62
34676598 2022
34
Hair shaft miniaturization causes stem cell depletion through mechanosensory signals mediated by a Piezo1-calcium-TNF-α axis. 62
34624205 2022
35
Case Report: Bi-allelic missense variant in the desmocollin 3 gene causes hypotrichosis and recurrent skin vesicles. 62
36061207 2022
36
Effectiveness of a fluralaner spot-on formulation in a case of feline demodicosis due to Demodex cati. 62
35111330 2022
37
Case Report: Hereditary Fibrosing Poikiloderma With Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Presenting With Liver Cirrhosis and Steroid-Responsive Interstitial Pneumonia. 62
35601499 2022
38
Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®). 62
34847929 2021
39
Four hypotrichosis families with mutations in the gene LSS presenting with and without neurodevelopmental phenotypes. 62
34318586 2021
40
Application of topical gentamicin-a new era in the treatment of genodermatosis. 62
34787828 2021
41
Rehabilitation of ectodermal dysplasia patient with a telescopic denture in the maxilla and mandibular implant assisted overdenture: A case report. 62
34938562 2021
42
A dominant-negative SOX18 mutant disrupts multiple regulatory layers essential to transcription factor activity. 62
34570228 2021
43
Characterization of EDARADD gene mutations responsible for hypohidrotic ectodermal dysplasia. 62
34219261 2021
44
Recurrent c.459 C>A mutation of the PERP gene results in severe Olmsted syndrome with congenital hypotrichosis, atopic dermatitis, and growth retardation. 62
34265120 2021
45
Moniletrix of the scalp from almost normal aspect to total alopecia: variable intrafamilial expressiveness. 62
34272078 2021
46
Isolated autosomal recessive woolly hair/hypotrichosis: genetics, pathogenesis and therapies. 62
33988877 2021
47
Gene Mutations of the Three Ectodysplasin Pathway Key Players (EDA, EDAR, and EDARADD) Account for More than 60% of Egyptian Ectodermal Dysplasia: A Report of Seven Novel Mutations. 62
34573371 2021
48
Additional causal SNRPE mutations in hereditary hypotrichosis simplex. 62
33792916 2021
49
Hypotrichosis-lymphedema-telangiectasia syndrome: Report of ileal atresia associated with a SOX18 de novo pathogenic variant and review of the phenotypic spectrum. 62
33851505 2021
50
A KRT71 Loss-of-Function Variant Results in Inner Root Sheath Dysplasia and Recessive Congenital Hypotrichosis of Hereford Cattle. 62
34356054 2021

Variations for Hypotrichosis

Expression for Hypotrichosis

Search GEO for disease gene expression data for Hypotrichosis.

Pathways for Hypotrichosis

Pathways related to Hypotrichosis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.64 KRT74 KRT71 KRT25 DSG4 DSC3 CDSN

GO Terms for Hypotrichosis

Cellular components related to Hypotrichosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cornified envelope GO:0001533 9.35 DSG4 DSC3 CDSN
2 desmosome GO:0030057 9.02 DSG4 DSC3 CDSN

Biological processes related to Hypotrichosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 keratinization GO:0031424 9.8 KRT74 KRT71 CDH3
2 cell-cell adhesion GO:0098609 9.73 DSG4 DSC3 CDSN CDH3
3 intermediate filament organization GO:0045109 9.63 KRT74 KRT71 KRT25
4 hair cycle process GO:0022405 9.26 SOX18 CDH3
5 hair follicle development GO:0001942 9.1 SOX18 DSG4 APCDD1

Sources for Hypotrichosis

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....